Header
Ihr Suchergebnis
Sie recherchieren derzeit unangemeldet.Melden Sie sich an (Login) um den vollen Funktionsumfang der Datenbank nutzen zu können.
Sie suchen in allen Bereichen nach dem Autor Kloft M.
In der Rubrik Zeitschriften haben wir 2 Beiträge für Sie gefunden
-
MerkenAutomation of Unstructured Data Transformation for Regulatory and Identification of Medicinal Products
Rubrik: Praxis
(Treffer aus pharmind, Nr. 10, Seite 1354 (2020))
Werner J | Kloft M | Gurulingappa H | Schneider D | Schlaps D
Automation of Unstructured Data Transformation for Regulatory and Identification of Medicinal Products / Text Mining for Merck Pharma Regulatory Intelligence · Werner J1, Kloft M2, Gurulingappa H2, Schneider D2, Schlaps D3 · 1Merck Healthcare KGaA, Darmstadt und Merck KGaA, Darmstadt und IT Consulting Life Science, Wessobrunn
Speech is the oldest and most spread out type of communication of mankind. The written speech, text, is somewhat newer but follows the same principles as speech and is therefore unstructured and makes it difficult for machines to grasp the meaning of text. Although living in the dawn of data age, we are still communicating by exchanging unstructured text. Due to our digitalized world we can generate huge amounts of textual information and distribute these in a very short time. The desire to evaluate this information automatically, as it is standard e.g. for a data warehouse, is growing. With today’s ...
-
MerkenIdentification of Medicinal Products: A Master Data Management Initiative
Rubrik: Fachthemen
(Treffer aus pharmind, Nr. 08, Seite 1057 (2019))
Herrmann A | Werner J | Kloft M
Identification of Medicinal Products: A Master Data Management Initiative / Herrmann et al. • Medicinal Products · Herrmann A, Werner J, Kloft M · Merck, Darmstadt
Asked to define synergies, the famous American writer Mark Twain stated “Synergy – the bonus that is achieved when things work together harmoniously” [ 2 ]. While this statement was made over a century ago, it can still be applied to describe the current initiatives being carried out by Merck as part of their efforts to fulfill the requirements set out by the Identification of Medicinal Products (IDMP). This initiative is the successor of the Extended EudraVigilance Medicinal Product Dictionary (XEVMPD), also commonly referred to as article 57 database, which aimed at establishing a data processing system for the reporting and ...
